Orca Bio

Manager, Global Quality Management System (QMS)

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a Bachelor's degree in a scientific or engineering discipline, with an advanced degree being preferred. A minimum of 5+ years of relevant Quality Assurance or Quality Systems experience in a GxP-regulated environment is required, including 2-3 years in a leadership role. Strong knowledge of global quality regulations and standards such as FDA, EMA, ICH, ISO 9001, 21 CFR Parts 210/211/820, and EU GMP is essential. Proven experience in leading Quality Management Review, internal audit programs, supplier management processes, and validation oversight is necessary. Demonstrated success in establishing and trending quality performance metrics and KPIs, along with experience supporting or administering electronic QMS systems and partnering with IT for system enhancements, is required. Experience working in a multi-site or global quality organization is strongly preferred. Excellent organizational, analytical, and communication skills, with the ability to influence and collaborate across functions, are also required.

Responsibilities

The Manager, Global QMS will lead and manage the global Quality Management Review (QMR) process, overseeing data collection, analysis, and reporting. This role is responsible for the global internal audit program, including planning, execution, reporting, and CAPA tracking. The manager will own the supplier qualification and management program, encompassing risk assessments, audits, and monitoring. They will drive global inspection readiness activities for health authority inspections and provide oversight and guidance to site QMR administrators for consistent quality system implementation. Key responsibilities include establishing and monitoring global QMS KPIs, trending quality metrics, and partnering with IT for QMS system enhancements, including defining requirements, prioritization, and validation. The role involves reviewing and approving validation documentation for global enterprise systems and collaborating with leadership teams to drive continuous improvement initiatives. The manager will also represent the Quality organization in interactions with external auditors, suppliers, and regulatory agencies as needed.

Skills

Quality Management System (QMS)
Regulatory Compliance
Internal Audits
Supplier Management
Inspection Readiness
GxP
FDA
EMA
Data Analysis
Risk Assessment
Corrective and Preventive Actions (CAPA)

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI